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Antimicrobial resistance in 
commensal faecal escherichia 
coli of hospitalised horses
AbStrACt
The objective of this study was to examine the impact of hospitalisation and antimicrobial drug administration on the prevalence of 
resistance in commensal faecal E. coli of horses. Faecal samples were collected from ten hospitalised horses treated with antimicrobials, 
ten hospitalised horses not treated with antimicrobials and nine non-hospitalised horses over a consecutive five day period and 
susceptibility testing was performed on isolated E. coli. Results revealed that hospitalisation alone was associated with increased 
prevalence of antimicrobial resistance and multidrug resistance in commensal E. coli of horses. Due to the risk of transfer of resistance 
between commensal and pathogenic bacteria, veterinarians need to be aware of possible resistance in commensal bacteria when treating 
hospitalised horses.
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iNtroduCtioN
Since their introduction in the 1930s, antimicrobials 
have revolutionised the treatment of infectious disease 
in human and veterinary patients, significantly enhancing 
treatment success and outcome. However in recent years 
it has become obvious that the frequent and sometimes 
indiscriminate use of these compounds in both human and 
veterinary medicine has selected for resistance among 
bacteria with an associated increase in morbidity and 
mortality from infectious disease (Morley et al. 2005; 
Mulvey and Simor 2009).
Antimicrobial use, whether for therapy or prevention of 
bacterial diseases, will result in selection for antimicrobial 
resistant micro-organisms by elimination of susceptible 
bacteria (Levy and Marshall 2004). Resistance is classified 
as intrinsic (naturally present) or acquired. Acquired 
resistance can arise because of chromosomal mutation or, 
more importantly, through the acquisition of transferable 
genetic material (Dargatz et al. 2000). Following the use 
of antimicrobial compounds resistance emerges, not 
only among pathogens but also among the endogenous 
microflora of animals (van den Bogaard and Stobberingh 
1999). Although resistance in these commensal bacteria 
may be of no consequence in one host species, these 
organisms may cause disease in other hosts and resistant 
commensal bacteria can serve as reservoirs of resistance 
genes (Morley et al. 2005). For example, antibiotic-
resistant bacteria from animals can colonise or infect 
humans via occupational exposure or via the food chain 
and resistance genes can be transferred from bacteria of 
animal origin to human pathogens in the intestinal flora of 
humans (van den Bogaard and Stobberingh 1999).
In the past decade, infection of patients in human 
hospitals with antimicrobial-resistant pathogens has 
become a common occurrence and is now recognised 
to be of growing concern in veterinary hospitals also. 
In human medicine, hospitals are considered to be a 
significant source of resistant bacteria although healthy 
people living outside hospitals may also be important 
reservoirs of resistance genes (van den Bogaard and 
Stobberingh 1999; Paterson 2006). In equine hospitals, 
outbreaks of disease involving multidrug-resistant bacteria 
have occurred (Seguin et al. 1999; Ward et al. 2005) 
and in the USA commensal bacteria of hospitalised 
horses have been shown to have a higher prevalence of 
antimicrobial resistance when compared to commensal 
bacteria of horses in their normal stable or field 
environment (Dunowska et al. 2006). 
Antimicrobial resistance is one of the most critical current 
issues in human and veterinary medicine (Southwood 
2006), with many organisms resistant to multiple classes 
of antimicrobial compound (Mulvey and Simor 2009). In 
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horses, multidrug resistance (MDR) has been observed in 
pathogenic and commensal bacteria including Salmonella 
Typhimurium, Staphylococcus aureus and E. coli (Anzai 
et al. 1987; Bucknell et al. 1997; Seguin et al. 1999; 
Ward et al. 2005; Dunowska et al. 2006). While the 
identification of MDR strains of bacteria in horses has 
implications in the treatment of bacterial infections 
in this species, public health implications are also an 
important concern. Many horses are companion animals 
and some enter the food chain; therefore, the presence 
of antimicrobial resistance in the bacterial flora of horses 
poses a risk to public health.
There are limited data in Europe on antimicrobial 
resistance in hospitalised horses and the aim of this 
study was to examine the impact of hospitalisation 
and antimicrobial administration on the prevalence of 
resistance and MDR in commensal faecal E. coli of 
horses. This study also investigated the effects of duration 
of hospitalisation on the prevalence of antimicrobial 
resistance and susceptibility of isolates to antimicrobial 
drugs commonly used in horses and those normally 
reserved for use in humans.
mAteriAlS ANd methodS
study overview – This was an observational study in 
which faecal samples were collected over a six month 
period (January 2008 through July 2008) from three 
different groups of horses. Three faecal samples were 
obtained from each horse over a period of five consecutive 
days. E. coli recovered from each faecal sample were 
subsequently evaluated to determine their susceptibility to 
a panel of antimicrobial compounds.
study population – Horses included in the study were 
those that were hospitalised at the University Veterinary 
Hospital (UVH) during the study period (denoted as Groups 
A and B) or horses that belonged to a closed herd owned 
by the University (denoted as Group C). Group A consisted 
of hospitalised horses that were treated with various 
systemic antimicrobial agents (penicillin, gentamicin or 
potentiated sulphonamides, or combinations of the former) 
starting within 24 hours of admission, and continuing for at 
least four days. Group B consisted of horses hospitalised 
for the same duration that did not receive antimicrobial 
agents. Group C horses were housed in their normal 
stable environment at a site remote from the hospital 
and were considered healthy based on their history and 
physical examination. Horses were excluded from the 
study if they were either less than two years old, had been 
treated with antimicrobial agents within the two weeks 
prior to presentation to the hospital or were presented for 
complaints involving the gastrointestinal system.
sample collection – For all horses, faecal samples 
were collected from the top of a fresh faecal pile into a 
sterile 20 ml universal container up to the 20 ml mark. 
Samples were collected on days one, three and five of 
hospitalisation for groups A and B and on days one, 
three and five of a consecutive five day period for horses 
in group C. For groups A and B, the day one faecal 
sample was collected as close as possible to the time of 
hospital admission and was always within twelve hours of 
admission. All samples taken on days three and five were 
collected 48 hours after the previous sample (+/- three 
hours). All samples were immediately refrigerated until the 
time of processing.
culture methods – All faecal samples were processed 
within 72 hours of collection. Standard bacterial culture 
was used to recover E. coli from the specimens. Briefly, 
a swab taken from each sample was plated directly onto 
a MacConkey No. 2 (Oxoid Limited) agar plate that was 
incubated at 37ºC for 18 to 24 hours. Up to five randomly 
selected isolates (minimum of three) from each faecal 
sample, presumptively identified as E. coli on the basis 
of colony morphology and lactose fermentation, were sub-
cultured onto a Harlequin TBGA agar (Lab M Ltd) plate that 
was incubated at 37ºC for 18 to 24 hours. The presence 
of a blue-green colony colour on the Harlequin TBGA agar 
plate was considered as positive identification of E. coli. 
Table 1: Disc strength, zones of inhibition, WHO and OIE rank of each antimicrobial tested.
Antimicrobial Disc  Disc Strength Zones of inhibition (mm) WHO rank 
2007
OIE rank 2007 
(including horses)
Resistant Intermediate Susceptible
Gentamicin 10 mcg ≤ 12 13-14 ≥ 15 Critical Critical 
Amoxicillin Clavulanate 20/10 mcg ≤ 13 14-17 ≥ 18 Critical Critical
Ampicillin 10 mcg ≤ 13 14-16 ≥ 17 Critical Critical
Cefpodoxime 10 mcg ≤ 17 18-20 ≥ 21 Critical
Ceftiofur 30 mcg ≤ 19 20-23 ≥ 24 Critical
Cefquinome 30 mcg ≤ 19 20-22 ≥ 23 Critical
Chloramphenicol 30 mcg ≤ 12 13-17 ≥ 18 Florphenicol listed as critical
Chloramphenicol used as indicator 
Ciprofloxacin 5 mcg ≤ 15 16-20 ≥ 21 Critical
Marbofloxacin 5 mcg ≤ 14 15-18 ≥ 19 Critical
Colistin 25 mcg ≤ 14 ≥ 15 Critical
Trimethoprim sulphamethoxazole (1.25/23.75) 
25 mcg
≤ 10 11-15 ≥ 16 Highly 
important
Critical
Tetracycline 30 mcg ≤ 14 15-18 ≥ 19 Highly 
important
Critical
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All suspect isolates that gave inconclusive results on 
Harlequin TBGA agar, as well as a random selection of 
isolates positive on Harlequin TBGA agar, were confirmed 
as E. coli using API 32E (Biomerieux Inc). 
antimicrobial susceptibility testing – Susceptibility 
testing for 12 antimicrobials, from seven different 
antimicrobial classes (aminoglycosides [gentamicin], 
β-lactams [amoxicillin clavulanate, ampicillin, cefpodoxime, 
cefquinome, ceftiofur], chloramphenicol [chloramphenicol], 
fluoroquinolones [ciprofloxacin, marbofloxacin], polymyxin 
[colistin], potentiated sulphonamides [trimethoprim 
sulphamethoxazole], tetracyclines [tetracycline]) was 
performed on each isolate using the Clinical and 
Laboratory Standards Institute (CLSI) disc diffusion method 
(CLSI, 2005). The antimicrobials tested were selected 
based on their WHO and OIE classification (Table 1) and 
their frequency of use in horses in Ireland. Isolates were 
categorised as susceptible, of intermediate susceptibility 
or resistant to each antimicrobial (Table 1). For the purposes 
of statistical analysis isolates of intermediate susceptibility 
were considered to be sensitive. MDR was defined as 
resistance to three or more antimicrobial classes.
 
dAtA mANAgemeNt ANd StAtiStiCAl 
ANAlySiS
Data were entered into and managed with Microsoft Office 
Excel 2007 (Microsoft Corporation) and analysed using 
Stata version 10 (Stata Corp). A horse was classified as 
demonstrating antimicrobial resistance if at least one 
isolate showed resistance to at least one antimicrobial. 
A horse was classified as demonstrating MDR if at least 
one isolate showed resistance to at least three classes of 
antimicrobials. Microsoft Office Excel was used to calculate 
the prevalence of resistance and MDR for each group 
of horses. A number of independent variables including 
horse, age, breed, sex, hospitalisation and treatment were 
assessed for each day of sampling using exact logistic 
regression (stata exlogistic) with the horse as the unit of 
interest. Due to the diversity of antimicrobial treatment 
protocols within group A horses, treatment was considered 
as a single effect for statistical analysis. The outcomes of 
interest were resistance status and MDR status. Univariate 
screening was performed so that variables with P<0.20 
at the univariate level became candidates for the model. 
Only hospitalisation, treatment and day of sampling were 
significant at P < 0.20. Multivariable analysis of the effects 
of treatment and day of sampling were performed using 
logistic generalised estimating equations (stata xtgee) 
to account for repeated measures within horses. As no 
group C (non-hospitalised) horses required treatment 
or developed MDR, the model was used to assess 
hospitalised horses only. No interaction terms were 
considered in the model because of the sample size.
reSultS
study population - A total of 29 horses were evaluated in 
the study (group A, n=10; group B, n=10; group C, n=9). 
The average age of all horses was 9 years, ranging from 
2 to 31 years. The population was composed of a mix of 
breeds including Irish Sporthorses (n=16), Cobs (n=7), 
Thoroughbreds (n=2), Shetland ponies (n=2), Clydesdale 
(n=1) and an Irish draught (n=1).
ANtimiCrobiAl reSiStANCe ANd multidrug 
reSiStANCe
Descriptive analysis 
A total of 412 E. coli isolates were tested for susceptibility 
to the selected antimicrobial agents. Of these, 28.6% 
(118/412) were resistant to at least one antimicrobial 
while 53.4% (63/118) of the resistant isolates 
demonstrated MDR.
Group A - Between days one and five there was an increase 
in the prevalence of horses with at least one isolate 
resistant to at least one of the antimicrobials tested (Figure 
1). A similar pattern was observed for MDR isolates in this 
group (Figure 1). 
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Fig. 1: The percentage 
of horses in each 
study group with at 
least one E. coli 
isolate showing 
resistance to at least 
one antimicrobial 
or multidrug 
resistance (MDR) on 
each day of sample 
collection (Group A 
(n=10) - hospitalised 
horses treated with 
antimicrobials, 
Group B (n=10) - 
hospitalised horses 
not treated with 
antimicrobials, 
Group C (n=9) - non-
hospitalised untreated 
horses).
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Group B – The prevalence of horses with at least one 
isolate resistant to at least one antimicrobial tested 
increased between days one and three and decreased by 
day five (Figure 1) with a similar pattern observed for MDR 
isolates (Figure 1). 
Group C - Antimicrobial resistance was not detected in any 
isolates from day one samples but was detected in one 
horse on day three and five (Figure 1). MDR was not detected 
in any isolates. 
Descriptive analysis 
The result of the exact logistic regression showed 
hospitalisation on days three and five was significantly 
associated with general antimicrobial resistance status 
(Table 2) and MDR (Table 3). The results of the multivariable 
analysis in hospitalised horses showed no significant effect 
of treatment on general antimicrobial resistance status 
(Table 4) and MDR (Table 5). Day of sampling was associated 
with increased general antimicrobial resistance status 
(Table 4) and MDR (Table 5). The effect of day of sampling on 
MDR increased on day five. Overall, hospitalisation status 
and day of sampling had the greatest association with the 
occurrence of general antimicrobial resistance and MDR.
reSiStANCe to iNdiViduAl ANtimiCrobiAlS
The overall percentage of individual isolates that were 
resistant to each antimicrobial tested is shown in Table 6.
Figure 2 and 3 show the percentage of horses in group A and 
B respectively, that have at least one E. coli isolate showing 
resistance to a particular antimicrobial on days one, three 
or five of hospitalisation. 
In Group C, resistance to chloramphenicol was detected in 
one horse on day three and again on day five. Resistance 
to any other antimicrobial class was not detected (data not 
shown). 
diSCuSSioN 
In both humans and animals it is acknowledged that 
antimicrobial use is associated with the development of 
antimicrobial resistance and that resistance develops 
not only in pathogenic bacteria but also in commensal 
organisms including E. coli (Prescott 2000; McEwen 
and Fedorka-Cray 2002; Gustafsson et al. 2003; van de 
Sande-Bruinsma et al. 2008). In this study it is likely that 
the use of antimicrobials in group A horses selected for 
more resistant populations of faecal E. coli during the 
hospitalisation period.  However, increased prevalence of 
antimicrobial resistance in group B horses on days three 
and five of hospitalisation compared to the prevalence 
at admission cannot be attributed to antimicrobial 
administration and suggests that hospitalisation is 
associated with higher levels of resistance in commensal 
faecal E. coli of horses regardless of whether they have 
received treatment with antimicrobials. This important 
finding is consistent with the results of a previous study 
in the USA in which hospitalised horses not treated 
Table 5: Multivariable analysis of the effects of treatment and day of sampling 
on MDR in hospitalised horses.
Variable  Odds ratio 95% Confidence Intervals p-value
Treatment 1.00 0.23 4.27 1.000
Day 3 7.36 1.80 30.07 0.005
Day 5 11.00 2.69 44.93 0.001
Constant 0.11 0.02 0.57 0.008
Table 6: The overall percentage of individual isolates resistant to each 
antimicrobial (n=412)
Antimicrobial Percentage of isolates resistant
Ampicillin 20.4%
Amoxicillin Clavulanate 0.5%
Ceftiofur  9.2%
Cefquinome 9.2%
Cefpodoxime 9.5%
Marbofloxacin 1.7%
Ciprofloxacin 1.7%
Tetracycline 17.5%
Colistin 0.7%
Gentamicin 0.5%
Trimethoprim sulphamethoxazole 23.8%
Chloramphenicol 10.7%
Table 2: Exact logistic regression results for the effect of hospitalisation on 
resistance to any individual antimicrobial on days 1, 3 and 5 of sampling
Odds ratio 95% Confidence Intervals p-value
Day 1 5.88a 0.75 + inf 0.099
Day 3 20.99 2.05 1133.15 0.004
Day 5 20.99 2.05 1133.15 0.004
(a) median unbiased estimates
Table 3: Exact logistic regression results for the effect of hospitalisation on 
MDR status on days 1, 3 and 5 of sampling. 
Odds ratio 95% Confidence Intervals p-value
Day 1 1.12a 0.08 + inf 0.936
Day 3 8.88a 1.16 + inf 0.034
Day 5 13.05a 1.72 + inf 0.010
(a) median unbiased estimates
Table 4: Multivariable analysis of the effects of treatment and day of sampling 
on resistance to any individual antimicrobial in hospitalised horses.
Variable  Odds ratio 95% Confidence Intervals p-value
Treatment 1.19 0.32 4.41 0.797
Day 3 5.59 1.61 19.39 0.007
Day 5 5.59 1.61 19.39 0.007
Constant 0.49 0.16 1.54 0.224
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with antimicrobials for at least four days prior to sample 
collection were significantly more likely to have resistant 
faecal E. coli isolates when compared to untreated horses 
in the community (Dunowska et al. 2006). Infections 
obtained from the hospital environment represent a major 
problem in human hospitals, with similar problems with 
these types of infections emerging in veterinary medicine. 
Epidemiological studies of small animal intensive care 
units have highlighted the importance of the environmental 
reservoir in the development of outbreaks of infections in 
veterinary hospitals. In one study a multiple-antimicrobial 
resistant strain of Acinetobacter baumannii was found to 
have been transferred between dogs, cats and a horse 
within the same hospital (Boerlin et al. 2001). It is 
speculated that hospitalisation may have resulted in an 
increase in resistance in horses in group B in this study 
due to exposure of horses to resistant strains of bacteria 
in the hospital environment or transfer of resistant bacteria 
or antimicrobial resistance genes from antimicrobial treated 
horses to untreated horses by direct contact or routine 
husbandry procedures; however, further investigation will 
be necessary to identify the exact cause. An interesting 
observation in group B horses is the decrease in 
resistance prevalence seen between days three and five. 
No explanation could be identified for this trend and an 
evaluation of a larger population would be necessary to 
explore this finding further.
Resistance patterns of E. coli isolated from samples 
collected at the time of hospital admission were assumed 
to be representative of resistance in the general equine 
population. However, the prevalence of resistance was 
found to be higher in hospital admission samples compared 
to samples from control horses (group C). This difference 
may be due to the increased likelihood that horses being 
admitted to hospital for illness may have been treated 
with antimicrobials prior to the two weeks before hospital 
admission. In this study no horse had been treated with 
antimicrobials for at least two weeks prior to inclusion in 
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Fig 3: The 
percentage of 
horses in Group 
B (hospitalised 
horses not 
treated with 
antimicrobials, 
n=10) with at 
least one E. 
coli isolate 
showing 
resistance to 
a particular 
antimicrobial 
on days one, 
three or five of 
hospitalisation. 
Fig 2: The 
percentage of 
horses in Group 
A (hospitalised 
horses 
treated with 
antimicrobials, 
n=10) with at 
least one E. 
coli isolate 
showing 
resistance to 
a particular 
antimicrobial 
on days one, 
three or five of 
hospitalisation. 
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the study but it is not known in horses how long the effect 
of antimicrobial administration will influence the resistance 
patterns of the intestinal flora. In humans the commensal 
microflora may return to normal following the completion 
of a course of antimicrobial treatment.  However, selected 
resistant commensal bacteria may also persist for years 
(Gustafsson et al. 2003). The control horses used in this 
study belonged to a closed herd and it is also possible that 
the prevalence of antimicrobial resistance in this group was 
lower due to increased biosecurity, including the absence 
of movement of animals from this group and resulting lack 
of exposure to different environments or to horses outside 
the herd. 
Infections with MDR bacteria are a major problem in human 
and veterinary medicine. The development of MDR results 
in increased morbidity and mortality in human and equine 
patients as well as increased cost of treatment through 
increased length of hospital stay, the necessity to use 
multiple and more expensive drugs for effective treatment 
and the increased costs of infection control (Levy and 
Marshall 2004; Tenover 2006: Ward et al. 2005). MDR has 
previously been reported in bacteria isolated from horses 
including E. coli (Dunowska et al. 2006), Acinetobacter 
baumannii (Boerlin et al. 2001), S. aureus (Seguin et 
al. 1999) and S. Typhimurium (Ward et al. 2005). In the 
current study E. coli demonstrating MDR were isolated 
from the faeces of hospitalised horses; however, E. coli 
may act as opportunistic pathogens also, causing disease. 
The primary mechanism for the development of MDR is 
through genetic exchange mechanisms (Tenover 2006). 
Enterobacteriaceae are capable of exchanging resistance 
genes under intestinal conditions in animals (Blake et al. 
2003) and thus commensal E. coli in horses could act 
as a reservoir of resistance genes that could potentially 
be transferred to other animals or humans. The influence 
that antimicrobial resistance in animals has on humans 
is currently controversial and it is unknown how frequently 
bacteria from animals colonise the human gut and transfer 
resistance genes. Transmission of bacteria such as MRSA 
from horses to humans and humans to horses (Seguin et 
al. 1999; Weese and Lefebvre 2007) has been identified 
both in veterinary hospitals and in the community, and the 
same possibilities for transmission must be considered for 
other bacteria.
Samples were collected over a five-day period of 
hospitalisation, as this was the average time that horses 
meeting the inclusion criteria were likely to remain in the 
hospital. Increasing prevalence of antimicrobial resistance 
and MDR was seen within two days of hospitalisation in 
both groups of hospitalised horses and highlights the 
speed at which resistant E. coli populations can develop. 
It has been shown that genetic transfer of determinants 
for drug resistance can occur rapidly in vitro, but frequency 
of transfer in vivo is lower (Prescott 2000); therefore, it 
is speculated that the most likely reason for the rapid 
development of resistant bacterial populations in horses 
treated with antimicrobials is the elimination of susceptible 
bacterial populations, and only to a lesser extent from 
the genetic transfer of resistance. The mechanism for 
the rapid development of antimicrobial resistance in the 
hospitalised untreated horses is unclear; however, it is 
possible that resistant bacteria were acquired from the 
hospital environment and after a period of two days could 
be detected in the faeces.
In this study resistance to potentiated sulphonamide 
antibiotics was most commonly seen, followed by 
resistance to ampicillin and tetracycline. These results 
agree in part with those of a previous study in the USA 
investigating antimicrobial susceptibility patterns of 
commensal E. coli in horses that showed resistance to 
sulphonamides (not investigated in the current study) 
and potentiated sulphonamides was most common; 
however, this was followed by resistance to gentamicin and 
tetracycline (Dunowska et al. 2006). The differences in 
results between the two studies may reflect geographical 
variations in bacterial populations or equine hospital 
environments, or different selection pressures due to 
variations in the use of antimicrobials. In human and 
animal studies the use of a particular antimicrobial 
has been shown to select for bacterial populations with 
resistance to that antimicrobial (Prescott 2000; van de 
Sande-Bruinsma et al. 2008); however, in the current 
study resistance to gentamicin in hospitalised horses was 
uncommon despite this being one of the most frequently 
used antimicrobials within the hospital. 
An interesting observation in the current study is the 
occurrence of resistance to third and fourth generation 
cephalosporins. No horse in the present study underwent 
treatment with cephalosporin antimicrobials during 
the study period; however, resistance to cefquinome, 
ceftiofur and cefpodoxime was seen in hospitalised 
horses regardless of whether they were treated with 
antimicrobials. Resistance to cefpodoxime was detected 
in one horse on admission to the hospital; however, all 
remaining isolates showing cephalosporin resistance 
were isolated from samples taken on days three or five of 
hospitalisation. It could be speculated that this pattern of 
resistance suggests that cephalosporin resistant bacteria 
or resistance genes were transferred to horses from the 
hospital environment; however, further investigation would 
be necessary to confirm this. Resistance to ceftiofur has 
been reported in farm animals (Li et al. 2007) and horses 
(Vo et al. 2007), and resistance to cefquinome has been 
reported in cattle (Guerin-Faublee et al. 2003); however, to 
the author’s knowledge this is the first report of resistance 
to cefquinome in E. coli of equine origin. The World Health 
Organisation (WHO) has defined third and fourth-generation 
cephalosporins as being “critically important” for use in 
humans (Collignon and Aarestrup 2007) with certain third-
generation cephalosporins being the therapy of choice 
in humans for treatment of infections caused by E. coli 
and Salmonella spp (Li et al. 2007). The development of 
resistance to these antimicrobials in animals is therefore 
not only a concern for treating disease in animals but 
also a major concern for public health. The presence 
of resistance to a fourth-generation cephalosporin is 
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especially worrying at a time when fewer new antimicrobials 
are becoming available and highlights the need for judicious 
use of available antimicrobials in both humans and 
animals. Results of a previous study in horses showed the 
administration of cephalosporins was positively associated 
with resistance to six or more antimicrobials (Dunowska et 
al. 2006), further supporting the need for judicious use of 
cephalosporins.
CoNCluSioNS
The results of the current study suggest that hospitalisation 
is an important risk factor associated with the development 
of antimicrobial resistance and MDR in commensal faecal 
E. coli of horses. Veterinarians need to be aware of the 
possibility of MDR in commensal bacteria in hospitalised 
horses as it may have implications for treatment of 
disease if resistance is transferred to pathogenic bacteria. 
Veterinarians should also be aware of the possible 
influence that antimicrobial resistance in horses has on 
public health. Resistance to third and fourth generation 
cephalosporins is concerning and highlights the need for 
judicious use of available antimicrobials in horses. Further 
large scale studies will be necessary to further explain or 
identify risk factors for the development of antimicrobial 
resistance in horses.
ACkNowledgemeNtS
The authors wish to thank Yvonne Abbott and Bernadette 
Legget for technical assistance with this project. 
refereNCeS
Anzai T, Kamada M, Ike K et al. (1987) Drug susceptibility 
of Escherichia coli isolated from foals with diarrhea 
and mares with metritis. Bulletin of Equine Research 
Institute 24, 42-50.
Blake DP, Hillman K, Fenlon DR et al. (2003) Transfer 
of antibiotic resistance between commensal and 
pathogenic members of the Enterobacteriaceae under 
ileal conditions. J Appl Microbiol 95, 428-436.
Boerlin P, Eugster S, Gaschen F et al. (2001) Transmission 
of opportunistic pathogens in a veterinary teaching 
hospital. Vet Microbiol 82, 347-359.
Bucknell DG, Gasser RB, Irving A et al. (1997) Antimicrobial 
resistance in Salmonella and Escherichia coli isolated 
from horses. Aust Vet J 75, 355-356.
CLSI (2005) Performance standards for antimicrobial 
disk diffusion susceptibility tests; Approved 
Standard. Clinical and Laboratory Standards Institute, 
Pennsylvania.
Collignon P, Aarestrup FM (2007) Extended-spectrum 
β-lactamases, food, and cephalosporin use in food 
animals. Clin Infect Dis 44, 1391-1392.
Dargatz DA, Traub-Dargatz JL, Sangster NC (2000) 
Antimicrobic and anthelmintic resistance. Vet Clin 
North Am Equine Pract 16, 515-536.
Dunowska M, Morley PS, Traub-Dargatz JL et al. (2006) 
Impact of hospitalization and antimicrobial drug 
administration on antimicrobial susceptibility patterns 
of commensal Escherichia coli isolated from the feces 
of horses. J Am Vet Med Assoc 228, 1909-1917.
Guérin-Faublée V, Carret G, Houffschmitt P (2003) In vitro 
activity of 10 antimicrobial agents against bacteria 
isolated from cows with clinical mastitis. Vet Rec 152, 
466-471.
Gustafsson I, Sjölund M, Torell E et al. (2003) Bacteria with 
increased mutation frequency and antibiotic resistance 
are enriched in the commensal flora of patients with 
high antibiotic usage. J Antimicrob Chemother 52, 645-
650.
Levy SB, Marshall B (2004) Antibacterial resistance 
worldwide: causes, challenges and responses. Nat 
Med Supplement 10, S122-129.
Li XZ, Mehrotra M, Ghimire S et al. (2007) β-Lactam 
resistance and β-lactamases in bacteria of animal 
origin. Vet Microbiol 121, 197-214.
McEwen SA, Fedorka-Cray PJ (2002) Antimicrobial use and 
resistance in animals. Clin Infect Dis 34 (Suppl 3), 
S93-S106.
Morley PS, Apley MD, Besser TE et al. (2005) Antimicrobial 
drug use in veterinary medicine. J Vet Int Med 19, 617-
629.
Mulvey MR, Simor AE (2009) Antimicrobial resistance in 
hospitals: How concerned should we be? CMAJ 180, 
408-415.
Paterson DL (2006) Resistance in gram-negative bacteria: 
Enterobacteriaceae. Am J Infect Control 34, S20-28.
Prescott JF (2000) Antimicrobial drug resistance and its 
epidemiology. In: Antimicrobial Therapy in Veterinary 
Medicine. Prescott JF, Baggot JD, Walker RD (eds). pp. 
35-36. Ames, Iowa State University Press.
Seguin JC, Walker RD, Caron JP et al. (1999) Methicillin-
resistant Staphylococcus aureus outbreak in a 
veterinary teaching hospital: potential human-to-animal 
transmission. J Clin Microbiol 37, 1459-1463.
Southwood LL (2006) Principles of antimicrobial therapy: 
what should we be using? Vet Clin North Am Equine 
Pract 22, 279-296.
Tenover FC (2006) Mechanisms of antimicrobial resistance 
in bacteria. Am J Med 119, S3-S10.
van de Sande-Bruinsma N, Grundmann H, Verloo D et al. 
(2008) European antimicrobial resistance surveillance 
system and European surveillance of antimicrobial 
consumption project groups. Antimicrobial drug use and 
resistance in Europe. Emerg Infect Dis 14, 1722-1730.
van den Bogaard AE, Stobberingh EE (1999) Antibiotic 
usage in animals: impact on bacterial resistance and 
public health. Drugs 58, 589-607.
Vo ATT, van Duijkeren E, Fluit AC et al. (2007) 
Characteristics of extended-spectrum cephalosporin-
resistant Escherichia coli and Klebsiella pneumoniae 
isolates from horses. Vet Microbiol 124, 248-255.
Ward MP, Brady TH, Couëtil LL et al. (2005) Investigation 
and control of an outbreak of salmonellosis caused 
by multidrug-resistant Salmonella Typhimurium in a 
population of hospitalized horses. Vet Microbiol 107, 
233-240.
Weese JS, Lefebvre SL (2007) Risk factors for methicillin-
resistant Staphylococcus aureus colonization in horses 
admitted to a veterinary teaching hospital. Can Vet J 
48, 921-926.
June_IVJ.indd   379 20/05/2010   16:31:48